Global Plasma Derived Therapy Market: Prominent Players and Market Ecosystem

calendar_today 02 May, 2023 person_outline Growth Plus Reports

 

Growth Plus Reports analyzed the global plasma derived therapy market, and it is estimated to be worth US$ 25.4 billion in 2021, while market revenue is expected to increase at a CAGR of 6.2% from 2022 to 2030. 

Plasma-derived therapies are medical products that are derived from human plasma, which is the clear liquid portion of the blood that remains after the blood cells have been removed. These therapies are used to treat a range of medical conditions, including immune deficiencies, bleeding disorders, and neurological disorders.

Top companies operating in the global plasma derived therapy market are:

• Biotest AGLFB
• CSL Limited
• Grifols, S.A.
• Takeda Pharmaceutical Company Limited
• Kedrion S.p.A

Market Ecosystem

• The plasma-derived therapy market can be segmented by protein-derived, application, end user, and region.
• The immunoglobulin segment accounts for the largest revenue share in the global plasma derived market’s protein derived segmentation.
• With the largest revenue during the forecast period, the hereditary diseases segment is expected to dominate the plasma derived therapy market based on application.
• With the largest revenue during the forecast period, the hospitals & clinics end-user segment is expected to dominate the plasma derived therapy market.

Conclusion

In summary, the global plasma-derived therapy market revenue is driven by the rising prevalence of chronic diseases, rising geriatric population, technological advancements, and increasing awareness. The market revenue is expected to continue to grow as demand for these therapies increases and as new and innovative plasma-derived therapies are developed and approved for use.